Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
25/08/202306:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
24/08/202307:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
24/08/202306:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
24/08/202306:05GlobeNewswire Inc.Regeneron Announces Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
24/08/202306:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
24/08/202306:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/08/202305:47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
23/08/202304:15GlobeNewswire Inc.Regeneron Announces Agreement with BARDA Supporting Development of Next-Generation Antibody Therapy for COVID-19 PreventionNASDAQ:REGNRegeneron Pharmaceuticals Inc
22/08/202302:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202309:39Dow Jones NewsRegeneron Pharmaceuticals Gets FDA OK for High-Dose Eylea Eye TreatmentNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202308:35GlobeNewswire Inc.EYLEA HD (aflibercept) Injection 8 mg Approved by FDA for Treatment of Wet Age-related Macular Degeneration (wAMD), Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR)NASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202307:16Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202304:42Dow Jones NewsRegeneron Pharmaceuticals' Veopoz Gets FDA Approval for Adults, ChildrenNASDAQ:REGNRegeneron Pharmaceuticals Inc
19/08/202303:43GlobeNewswire Inc.Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First Treatment for Children and Adults with CHAPLE DiseaseNASDAQ:REGNRegeneron Pharmaceuticals Inc
17/08/202322:30GlobeNewswire Inc.Odronextamab Receives EMA Filing Acceptance for Treatment of Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell LymphomaNASDAQ:REGNRegeneron Pharmaceuticals Inc
12/08/202306:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
11/08/202304:02Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
10/08/202321:00GlobeNewswire Inc.Two-year PULSAR Trial Results for Aflibercept 8 mg Demonstrate Durable Vision Gains at Extended Dosing Intervals in Wet Age-related Macular DegenerationNASDAQ:REGNRegeneron Pharmaceuticals Inc
10/08/202306:15Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/08/202323:34Dow Jones NewsDecibel Therapeutics Shares Surge on Regeneron AcquisitionNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/08/202322:14Dow Jones NewsRegeneron To Acquire Decibel TherapeuticsNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/08/202321:30GlobeNewswire Inc.Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss ProgramsNASDAQ:REGNRegeneron Pharmaceuticals Inc
04/08/202321:31IH Market NewsFriday’s Wall Street Highlights: Amazon, Apple, Fortinet, Atlassian, DraftKings, and moreNASDAQ:REGNRegeneron Pharmaceuticals Inc
04/08/202306:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
04/08/202306:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/08/202320:56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:REGNRegeneron Pharmaceuticals Inc
03/08/202320:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/08/202320:30GlobeNewswire Inc.Regeneron Reports Second Quarter 2023 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
02/08/202306:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:REGNRegeneron Pharmaceuticals Inc
01/08/202321:00GlobeNewswire Inc.Regeneron Announces the 2023 Winners of The Regeneron Prize for Creative InnovationNASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN